Digital Pharma is running out of names. Can an AI help? At Reuters Pharma USA, presenters showed off an AI aimed at reimagining the complex process of pharmaceutical naming.
News Regeneron swoops on genetic testing firm 23andMe DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
